Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tamar NIV was an Israeli healthcare technology company or subsidiary associated with the Tamar group, best known for developing the NIV Greenhouse, a protective hood system used during non-invasive ventilation. The product was designed to reduce aerosol spread and help protect healthcare workers while enabling CPAP and BiPAP treatment for patients with COVID-19 and other respiratory support needs. Publicly available information links Tamar NIV to Tamar Robotics and describes the business as leveraging engineering and robotic-technology capabilities to create hospital respiratory-protection solutions. Evidence of hospital deployment in Israel exists from 2020, but there is little recent public evidence of ongoing standalone corporate activity, financing, or an expanded pipeline. As a result, Tamar NIV appears to have been a small, niche medtech effort centered primarily on a single COVID-era product.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tamar NIV.